about
Morphological Alterations in Gastrocnemius and Soleus Muscles in Male and Female Mice in a Fibromyalgia ModelThe BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cellsAirtightness of lung parenchyma without a closing suture after atypical resection using the Nd:YAG Laser LIMAX 120Roscovitine has anti-proliferative and pro-apoptotic effects on glioblastoma cell lines: A pilot study.SIVmac₂₃₉-Nef down-regulates cell surface expression of CXCR4 in tumor cells and inhibits proliferation, migration and angiogenesis.Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-let-7b expression in liver cancer cell lines.Nef from SIV(mac239) decreases proliferation and migration of adenoid-cystic carcinoma cells and inhibits angiogenesis.MicroRNAs let7 expression in thyroid cancer: correlation with their deputed targets HMGA2 and SLC5A5.The dual EGF/VEGF receptor tyrosine kinase inhibitor AEE788 inhibits growth of human hepatocellular carcinoma xenografts in nude mice.Embryonic transcription factors CDX2 and Oct4 are overexpressed in neuroendocrine tumors of the ileum: a pilot study.Expression of hsa-let-7b-5p, hsa-let-7f-5p, and hsa-miR-222-3p and their putative targets HMGA2 and CDKN1B in typical and atypical carcinoid tumors of the lung.Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome.Ileal neuroendocrine tumors show elevated activation of mammalian target of rapamycin complex.The pan-deacetylase inhibitor panobinostat inhibits growth of hepatocellular carcinoma models by alternative pathways of apoptosis.Pharmacological Inhibition of Class IIA HDACs by LMK-235 in Pancreatic Neuroendocrine Tumor CellsPanobinostat mediated cell death: a novel therapeutic approach for osteosarcomaTargeting autophagy in liver cancerDual anticancer activity in a single compound: visible-light-induced apoptosis by an antiangiogenic iridium complexClinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCCEffects of multi and selective targeted tyrosine kinase inhibitors on function and signaling of different bladder cancer cellsGender Differences in Multiple Endocrine Neoplasia Type 1: Implications for Screening?Selumetinib Activity in Thyroid Cancer Cells: Modulation of Sodium Iodide Symporter and Associated miRNAsChemoprevention with Enalapril and Aspirin in Men1(+/T) Knockout Mouse Model
P50
Q27318264-327B023B-D7A9-4C33-9813-3A5C1744F9F0Q27340125-3820809D-A666-4199-AE83-9E5794F891C2Q35006602-8368B026-4F2E-45C6-B60C-AE2917665C06Q38855758-1E58207C-D574-4556-81C7-2BA3249B70ACQ39321041-24F9D9E9-E1D7-48C3-814E-6BEF08880D9EQ39334102-60049D71-1AA9-45C9-9F0E-6AA92CA52BA1Q39505952-6AC57D08-E367-4649-A90A-4CC926978627Q39934112-C3411843-6204-46DB-A10F-655EC820279BQ39936554-DF6E9479-235F-4476-8DBC-D6B941A5425BQ46116964-F5769FA7-50BE-444A-ADD1-BFBC8BA78BFFQ47247387-49B2ED54-EA7A-4F2A-BB06-2F32CD1814D7Q47848421-633111D9-B2E3-42BC-B2B4-65C495DC03E7Q50610047-06855708-C510-4053-83F7-0F8B55646BBEQ54688416-B92DB23A-9EEB-4ED6-A767-3B3FE4D6843EQ57471231-79175CF7-768F-4340-BD09-415E228578FDQ58779434-ECE734C8-4375-428C-8DA2-E3E309872527Q59353835-0051DB48-519F-4721-8439-EE0B31E2D88BQ82367578-D993AE39-E88E-444F-A13D-D7DE915D3509Q84465877-566FF7A0-6A2E-460A-85B4-B66F1C4D0EC4Q89391523-22981014-A161-4ACF-AC13-4C05A2F27ACEQ89942738-F6C58193-E3AC-4296-A405-EE93D8ABB951Q90293775-B71CBE09-674D-4B07-90B8-EE72E1B487EBQ90343922-8BAEDFF7-B46F-475F-A43A-ABAAA96150DD
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pietro Di Fazio
@ast
Pietro Di Fazio
@en
Pietro Di Fazio
@es
Pietro Di Fazio
@nl
type
label
Pietro Di Fazio
@ast
Pietro Di Fazio
@en
Pietro Di Fazio
@es
Pietro Di Fazio
@nl
prefLabel
Pietro Di Fazio
@ast
Pietro Di Fazio
@en
Pietro Di Fazio
@es
Pietro Di Fazio
@nl
P106
P1153
25421265700
P31
P496
0000-0003-0091-8498